World’s First Clinical Trial for anti-Abeta Vaccine Targeting Alzheimer’s Disease-like Characteristics in People with Down Syndrome

Categories: Blog, Clinical Trials, Ds / Alzheimer's Connection, Ds Research, News
PRESS RELEASE – Issued by AC Immune Studies AC Immune’s ACI-24, the first anti-amyloid vaccine for treatment of Alzheimer’s disease-like characteristics in people with Down syndrome Clinical Study is done in collaboration with University of California San Diego US NIH provides significant funding with an additional grant from the LuMind Research Down Syndrome Foundation Alzheimer’s …

Read More

Federal Budget Updates Related to Down Syndrome Research

Categories: Blog, Ds / Alzheimer's Connection, News
Our Dr. Harpold stays closely connected to and works in the world of research, not only Down syndrome and Alzheimer’s disease, but also relevant research endeavors at a broad scale. Here’s his take on the Federal 2016 Omnibus Budget Bill. By Dr. Michael Harpold, LuMind RDS Chief Scientific Officer The just enacted Federal 2016 Omnibus Budget …

Read More

Clinton Campaign Announces Investment Plan for Alzheimer’s Disease

Categories: Blog, Ds / Alzheimer's Connection, News
LuMind Research Down Syndrome Foundation applauds the development and announcement by the Clinton presidential campaign of a formal plan for new investment to prevent, treat, and make an Alzheimer’s disease cure possible by 2025, which includes a commitment to reach the $2 billion annual funding level for NIH’s dementia research. You can read more details on Clinton’s announced plan …

Read More

Awaken A Force

Categories: Blog, Ds / Alzheimer's Connection

By Alan Gard, Devoted Dad (and Jedi Knight Battling Darth Dementia) As December greets us this year, many are in a festive move as a special event approaches…namely the release of Star Wars: The Force Awakens. Over $50 million in presale tickets have already been sold. When was the last time you bought a ticket in …

Read More